Pneumonia can occur if Pseudomonas infects the lungs. Hospitalized adults with Pseudomonas and those who have recently ...

usually necessitates a more prolonged course of intravenous antibiotics as compared to pneumonia caused by the less virulent and more antibiotic sensitive Mycoplasma pneumoniae. Antibiotic ...

A study in The Annals of Family Medicine explored how chest X-ray results influence antibiotic initiation by general practitioners in France when managing patients with suspected pneumonia.

HMPV causes mild illness in most adults. However, it poses a higher risk to specific vulnerable groups. These people need to ...

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores ...

Hospital-acquired pneumonia is a common complication ... the available literature on the use of aerosolized antibiotics for treating HAP in adult patients. † Endotracheally instilled (ET ...

Wockhardt's novel antibiotic Miqnaf approved for CABP treatment, offering a promising monotherapy option for MDR pathogens.

Miqnaf is an antibiotic for treatment of community-acquired bacterial pneumonia, including those caused by multi-drug ...

Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can leave people feeling short of breath. With walking pneumonia, any ...

Pharmaceuticals firm Wockhardt Ltd on Thursday (January 2) announced that the Central Drugs Standard Control Organization ...

Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin, sold under Miqnaf brand, as a new treatment for community-acquired bacterial Pneumonia (CABP) in adults.